Comparison of cardiac troponin assays reveals assay-specific sensitivities in a clinical model of very acute myocardial injury
European Heart Journal: Acute Cardiovascular Care · 2025
DOI: 10.1093/ehjacc/zuaf064 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, 2025. Verfasst von Julius Obergassel und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistr. 52, Hamburg 20246, Ger…. Hauptthemen laut MEDLINE: Troponin I, Myocardial Infarction, Troponin T, Atrial Fibrillation. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: TRUST, Deutsche Herzstiftung, University of Hamburg.
Abstract (Originalsprache)
Aims
High-sensitivity cardiac troponin (hs-cTn) assays indicating myocardial injury are critical for the diagnosis of acute myocardial infarction (AMI), but their use to differentiate between acute and chronic myocardial injury is limited. This study aimed to assess the differential utility of three hs-cTn assays, targeting different troponin epitopes (proximal and/or central), to detect myocardial injury in a clinical model of acute myocardial injury by left-atrial ablation. Methods and results First, pre- and post-procedural serum samples were prospectively collected from 158 patients undergoing pulmonary vein isolation in a standardised setting. cTn-concentrations were measured using the high-sensitive Architect-cardiac troponin I (cTnI)-, Atellica-IM-cTnI-, and Elecsys-cTnT assays. Cardiac troponin I/T-concentrations and -ratios were compared, also to established AMI rule-in-thresholds. Second, 48 patients in which hs-cTn measurements were performed in clinical routine after ablation with a clinical indication were assessed for correlations between hs-cTn-levels, symptoms and electrocardiogram changes. The Atellica-assessed cTnI showed a doubled relative pre-to-post-procedural concentration increase compared to Architect-cTnI (39.6-fold vs. 20.5-fold; P = 0.0036). The Atellica-hs-cTnI/T-ratio had a 2.5 (95% confidence intervals (CI) 1.1,5.2) relative increase, while the Architect-cTnI-to-Elecsys-cTnT-ratio showed a 6.9 (95% CI 2.3,11.8) relative increase (P < 0.0001). In 78% of patients, at least one post-procedural cTn-concentration exceeded AMI rule-in-thresholds. Chronic kidney disease predicted higher pre-to-post-increases. In retrospectively analysed routine cTn-assessments after ablation, cTn-levels after ablation did not correlate with neither symptoms, electrocardiogram changes nor angiography findings.
Conclusion
The Atellica assay demonstrated enhanced sensitivity for very acute myocardial injury, likely via its additional recognition of the proximally located cTnI epitope. This suggests its potential to improve differentiation of acute from chronic myocardial injury, warranting further investigation to confirm its clinical utility in that setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistr. 52, Hamburg 20246, Germany.
- German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Germany.
- Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom.
- Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Center for Thrombosis and Hemostasis (CTH), Johannes Gutenberg University Medical Center, Mainz, Germany.
- Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
ORCID-Profile: Julius Obergassel, Marc D Lemoine, Laura C Sommerfeld, Jan L Rieß, Laura Rottner, Andreas Rillig, Andreas Metzner, Nils A Sörensen, Larissa Fabritz, Thomas Renné, Raphael Twerenbold, Stefan Blankenberg, Tanja Zeller, Paulus Kirchhof, Johannes T Neumann
Förderung
- TRUST
- Deutsche Herzstiftung
- University of Hamburg
- European Union MAESTRIA
- British Heart Foundation
- German Center for Cardiovascular Research
- German Ministry of Education and Research
- DZHK
Zitieren
APA
Obergassel, J., Lemoine, M. D., Sommerfeld, L. C., Rieß, J. L., Al-Aqili, S., Jäckle, S. J., Rottner, L., Rillig, A., Metzner, A., Sörensen, N. A., Fabritz, L., Renné, T., Twerenbold, R., Blankenberg, S., Zeller, T., Kirchhof, P., & Neumann, J. T. (2025). Comparison of cardiac troponin assays reveals assay-specific sensitivities in a clinical model of very acute myocardial injury. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuaf064
Vancouver
Obergassel J, Lemoine MD, Sommerfeld LC, Rieß JL, Al-Aqili S, Jäckle SJ, et al. Comparison of cardiac troponin assays reveals assay-specific sensitivities in a clinical model of very acute myocardial injury. European Heart Journal: Acute Cardiovascular Care. 2025. doi:10.1093/ehjacc/zuaf064
BibTeX
@article{Obergassel2025,
author = {Obergassel, Julius and Lemoine, Marc D and Sommerfeld, Laura C and Rieß, Jan L and Al-Aqili, Salah and Jäckle, Sandro J and Rottner, Laura and Rillig, Andreas and Metzner, Andreas and Sörensen, Nils A and Fabritz, Larissa and Renné, Thomas and Twerenbold, Raphael and Blankenberg, Stefan and Zeller, Tanja and Kirchhof, Paulus and Neumann, Johannes T},
title = {Comparison of cardiac troponin assays reveals assay-specific sensitivities in a clinical model of very acute myocardial injury},
journal = {European Heart Journal: Acute Cardiovascular Care},
year = {2025},
doi = {10.1093/ehjacc/zuaf064}
}
EUVIMED